| Literature DB >> 26444170 |
Dragana Milutinović1, Dragana Simin1, Davor Zec2.
Abstract
OBJECTIVES: to assess nurses' perceptions of risk factors for the development of phlebitis, with a special focus on the perception of phlebitic potentials of some infusion medications and solutions.Entities:
Mesh:
Year: 2015 PMID: 26444170 PMCID: PMC4623731 DOI: 10.1590/0104-1169.0192.2603
Source DB: PubMed Journal: Rev Lat Am Enfermagem ISSN: 0104-1169
− Demographic characteristics of participants (n=102). Novi Sad, Niš and Osijek, Serbia and Croatia, 2012
| Demographic variable | Category | Frequency Percentage | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | Male | 23 | 22.5 | Female | 79 | 77.5 | |||||||||
| Education | Secondary school | 63 | 61.8 | Technical College | 13 | 12.7 | 3 - year bachelor's degree | 22 | 21.6 | 4 - year bachelor's degree | 1 | 1.0 | Master's degree | 3 | 2.9 |
| Work setting | Surgical intensive care unit | 43 | 42.1 | Internal intensive care unit | 42 | 41.2 | Department of anaesthesia | 17 | 16.7 | Mean | SD* | ||||
| Age (years) | 33.2 | 7.2 | |||||||||||||
| Work experience (years) | 11.7 | 7.8 | |||||||||||||
*Standard deviation
−The nurses' perception of some risk factors for phlebitis in relation to educational level. Novi Sad, Niš and Osijek, Serbia and Croatia, 2012
Phlebitic potentials of intravenous antibiotics. Novi Sad, Niš and Osijek, Serbia and Croatia, 2012
| Generic Name | n* | Min. | Max. | Mean | SD† |
|---|---|---|---|---|---|
| Chlarithomycin | 42 | 1 | 5 | 2.21 | 1.04 |
| Azithromycin | 75 | 1 | 5 | 2.39 | 1.11 |
| Vancomycin | 94 | 1 | 5 | 3.12 | 1.26 |
| Aciclovir | 58 | 1 | 5 | 2.45 | 1.14 |
| Ceftazidime | 92 | 1 | 5 | 2.58 | 1.12 |
| Tigecycline | 71 | 1 | 5 | 2.83 | 1.06 |
| Imipenem/cilastatin | 92 | 1 | 5 | 2.59 | 1.16 |
| Ertapenem | 76 | 1 | 5 | 2.71 | 0.89 |
| Netilmicin | 71 | 1 | 5 | 2.55 | 1.03 |
| Cefotaxime | 81 | 1 | 5 | 2.36 | 1.02 |
| Ciprofloxacin | 94 | 1 | 5 | 2.64 | 1.28 |
| Benzylpenicillin | 65 | 1 | 5 | 3.06 | 1.13 |
| Clindamycin | 93 | 1 | 5 | 2.60 | 1.09 |
| Metronidazole | 96 | 1 | 5 | 2.39 | 1.23 |
| Cefuroxime | 96 | 1 | 5 | 2.26 | 1.17 |
| Gentamicin | 97 | 1 | 5 | 2.31 | 1.14 |
| Amikacin | 95 | 1 | 5 | 2.41 | 1.14 |
*n = Number of participants who rated the drug
†Standard deviation
− Phlebitic potentials of intravenous medications other than antibiotics. Novi Sad, Niš and Osijek, Serbia and Croatia, 2012
| Generic Name | n* | Min. | Max. | Mean | SD† |
|---|---|---|---|---|---|
| Diazepam | 89 | 1 | 5 | 2.17 | 1.27 |
| Epinephrine hydrochloride | 87 | 1 | 5 | 1.90 | 1.07 |
| Aminophylline | 91 | 1 | 5 | 2.58 | 1.18 |
| Pethidine hydrochloride | 54 | 1 | 4 | 2.24 | 0.97 |
| Digoxin | 86 | 1 | 5 | 2.16 | 1.13 |
| Amiodarone hydrochloride | 90 | 1 | 5 | 2.56 | 1.21 |
| Hydrocortisone | 84 | 1 | 5 | 2.37 | 1.31 |
| Metoclopramide | 90 | 1 | 5 | 2.01 | 1.02 |
| Morphine hydrochloride | 83 | 1 | 5 | 2.54 | 1.32 |
| Heparin | 86 | 1 | 5 | 1.93 | 1.15 |
| Furosemid | 89 | 1 | 5 | 1.87 | 0.97 |
| Calcium glubionate | 88 | 1 | 5 | 2.77 | 1.35 |
*n = Number of participants who rated the drug
†Standard deviation
− Phlebitic potentials of intravenous fluids. Novi Sad, Niš and Osijek, Serbia and Croatia, 2012
| Intravenous Fluid | n* | Min. | Max. | Mean | SD† |
|---|---|---|---|---|---|
| Glucose 10% | 90 | 1 | 4 | 1.74 | 0.91 |
| Glucose 5% | 92 | 1 | 5 | 1.65 | 0.95 |
| Intralipid lipids 20% | 71 | 1 | 5 | 3.11 | 1.37 |
| Amino acid 15% | 78 | 1 | 5 | 3.08 | 1.28 |
| Amino acid 10% | 83 | 1 | 5 | 3.08 | 1.35 |
| Amino acid 5% | 75 | 1 | 5 | 3.03 | 1.26 |
| Amino acid - Hepatosol8% | 69 | 1 | 5 | 2.93 | 1.31 |
| Vamin aminoacids 14 g | 34 | 1 | 5 | 2.82 | 1.16 |
| Emulsion for infusion (Glucose, Amino acids and electrolytes Fat emulsion) | 73 | 1 | 5 | 3.01 | 1.45 |
| Albumin (human) 20% | 88 | 1 | 5 | 2.30 | 1.19 |
| Polygeline infusion solution 3.5% | 70 | 1 | 5 | 1.93 | 1.01 |
| 6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium Chloride Injection | 89 | 1 | 5 | 1.84 | 0.93 |
| Erythrocyte concentrate | 93 | 1 | 5 | 2.67 | 1.21 |
| Fresh - frozen plasma | 92 | 1 | 5 | 2.45 | 1.17 |
| Ringer's solution | 91 | 1 | 4 | 1.62 | 0.82 |
| Hartmann's solution | 78 | 1 | 5 | 1.71 | 1.02 |
| Mannitol 10% | 88 | 1 | 5 | 2.03 | 0.96 |
| Mannitol 20% | 90 | 1 | 5 | 2.24 | 1.10 |
| Potassium chloride 7.4% | 93 | 1 | 5 | 3.39 | 1.32 |
| 0.9% Sodium Chloride Solution | 94 | 1 | 5 | 1.73 | 1.09 |
| Sodium Bicarbonate 8.4% | 90 | 1 | 5 | 2.44 | 1.19 |
*n = Number of participants who rated the fluid
†Standard deviation